Stock Expert AI
Equity research screen

JNJ vs. PFE: Detailed Stock Comparison

This page offers a detailed comparison of Johnson & Johnson (JNJ) and Pfizer (PFE). It facilitates a side-by-side evaluation of these two prominent pharmaceutical stocks, enabling investors to assess their relative strengths. This analysis helps to inform investment strategies based on key financial metrics and company profiles. The comparison is designed to provide a clear, concise overview of each company's position.

Quick Answer This page provides a comparison of Johnson & Johnson (JNJ) and Pfizer (PFE), examining their business models and market positions. The side-by-side analysis facilitates a quick assessment of each company. With recent market dynamics favoring healthcare stocks, a comparison of industry leaders like JNJ and PFE offers timely insights for investors. The shortlist is built using key financial metrics.
Screens40Average score79.50Updated2026-04-10Prices as ofOct 26, 2026 session

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.

MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.

20,000+ US companies analyzed

Johnson & Johnson (JNJ) vs. Pfizer (PFE): Key Differences

Johnson & Johnson (JNJ) and Pfizer (PFE) are major players in the healthcare sector, yet they present distinct investment profiles. JNJ is a diversified healthcare company with a broad range of products, while PFE focuses primarily on pharmaceuticals and vaccines. Understanding these differences is crucial for investors looking to allocate capital within the healthcare industry.

JNJ vs PFE: The Numbers

Side by side on the figures we publish for both companies. Not a ranking and not a recommendation — the same metrics, read off the same source, on the same day.

JNJ and PFE on five published metrics — MoonshotScore and P/E from our latest stored data; prices, day change and market cap as of the Oct 26, 2026 trading session (FMP quote). Source: Financial Modeling Prep, Yahoo Finance.
Metric JNJJohnson & JohnsonPFEPfizer Inc.
MoonshotScore 9069
Price $266.30$29.79
Change (1D) +0.94%-0.80%
Market cap $641.1B$169.8B
P/E ratio ——

A dash means we hold no published figure for that company — not a zero. Full analysis: JNJ · PFE.

Stock Comparison: JNJ vs. PFE

The comparison includes an overview of each company, along with relevant links to individual stock analysis pages. This allows for deeper investigation into either JNJ or PFE, as needed.
“MoonshotScore rates a US-listed stock 0 to 100 using five sector-relative pillars. Higher means stronger numbers across business quality, safety, valuation, growth and momentum. Eligible common stocks and ADRs only; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
— Stock Expert AI published methodology (how MoonshotScore works)

Questions worth resolving before acting on the screen

What are the MoonshotScores of JNJ and PFE?

JNJ (Johnson & Johnson) has a MoonshotScore of 90 out of 100 and PFE (Pfizer Inc.) has 69 (scores dated 2026-10-26). JNJ scores 21 points higher. The MoonshotScore is a model rating, not a recommendation.

What is the latest recorded share price of JNJ and PFE?

JNJ last recorded $266.30 and PFE $29.79 (quotes dated 2026-10-26). These are the last provider quotes we hold, not streaming prices.

Which is larger by market capitalization, JNJ or PFE?

JNJ has a market capitalization of $641.1B and PFE $169.8B (quotes dated 2026-10-26). JNJ is about 3.8 times the size of PFE by market value.

Explore More Research

Stock Expert AI provides data and analysis tools for educational purposes. This is not financial advice. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.